JP2016514677A5 - - Google Patents

Download PDF

Info

Publication number
JP2016514677A5
JP2016514677A5 JP2016502905A JP2016502905A JP2016514677A5 JP 2016514677 A5 JP2016514677 A5 JP 2016514677A5 JP 2016502905 A JP2016502905 A JP 2016502905A JP 2016502905 A JP2016502905 A JP 2016502905A JP 2016514677 A5 JP2016514677 A5 JP 2016514677A5
Authority
JP
Japan
Prior art keywords
composition
sodium sulfate
less
oral pharmaceutical
pharmaceutical tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016502905A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016514677A (ja
JP6441890B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/028805 external-priority patent/WO2014144407A1/en
Publication of JP2016514677A publication Critical patent/JP2016514677A/ja
Publication of JP2016514677A5 publication Critical patent/JP2016514677A5/ja
Application granted granted Critical
Publication of JP6441890B2 publication Critical patent/JP6441890B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016502905A 2013-03-15 2014-03-14 硫酸塩の両用経口薬学的組成物錠剤およびその使用の方法 Expired - Fee Related JP6441890B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361798759P 2013-03-15 2013-03-15
US61/798,759 2013-03-15
PCT/US2014/028805 WO2014144407A1 (en) 2013-03-15 2014-03-14 Dual use oral pharmaceutical composition tablets of sulfate saltes and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018219465A Division JP6724114B2 (ja) 2013-03-15 2018-11-22 硫酸塩の両用経口薬学的組成物錠剤およびその使用の方法

Publications (3)

Publication Number Publication Date
JP2016514677A JP2016514677A (ja) 2016-05-23
JP2016514677A5 true JP2016514677A5 (cg-RX-API-DMAC7.html) 2017-04-13
JP6441890B2 JP6441890B2 (ja) 2018-12-19

Family

ID=50680164

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016502905A Expired - Fee Related JP6441890B2 (ja) 2013-03-15 2014-03-14 硫酸塩の両用経口薬学的組成物錠剤およびその使用の方法
JP2018219465A Expired - Fee Related JP6724114B2 (ja) 2013-03-15 2018-11-22 硫酸塩の両用経口薬学的組成物錠剤およびその使用の方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018219465A Expired - Fee Related JP6724114B2 (ja) 2013-03-15 2018-11-22 硫酸塩の両用経口薬学的組成物錠剤およびその使用の方法

Country Status (25)

Country Link
US (2) US9919007B2 (cg-RX-API-DMAC7.html)
EP (2) EP3563838A1 (cg-RX-API-DMAC7.html)
JP (2) JP6441890B2 (cg-RX-API-DMAC7.html)
CN (2) CN108904462A (cg-RX-API-DMAC7.html)
AU (3) AU2014227598B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015019776A2 (cg-RX-API-DMAC7.html)
CA (1) CA2903283C (cg-RX-API-DMAC7.html)
CY (1) CY1122387T1 (cg-RX-API-DMAC7.html)
DK (1) DK2968174T3 (cg-RX-API-DMAC7.html)
EA (2) EA201992382A3 (cg-RX-API-DMAC7.html)
ES (1) ES2764462T3 (cg-RX-API-DMAC7.html)
HK (1) HK1214519A1 (cg-RX-API-DMAC7.html)
HR (1) HRP20192227T1 (cg-RX-API-DMAC7.html)
HU (1) HUE046754T2 (cg-RX-API-DMAC7.html)
IL (1) IL241367A0 (cg-RX-API-DMAC7.html)
LT (1) LT2968174T (cg-RX-API-DMAC7.html)
ME (1) ME03656B (cg-RX-API-DMAC7.html)
MX (1) MX377525B (cg-RX-API-DMAC7.html)
PE (1) PE20151543A1 (cg-RX-API-DMAC7.html)
PL (1) PL2968174T3 (cg-RX-API-DMAC7.html)
PT (1) PT2968174T (cg-RX-API-DMAC7.html)
RS (1) RS59667B1 (cg-RX-API-DMAC7.html)
SI (1) SI2968174T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201900716T1 (cg-RX-API-DMAC7.html)
WO (1) WO2014144407A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1214519A1 (zh) 2013-03-15 2016-07-29 Braintree Laboratories, Inc. 雙用途硫酸鹽口服藥物組合物片劑及其使用方法
WO2016040733A1 (en) * 2014-09-12 2016-03-17 Braintree Laboratories, Inc. Sulfate salt solution laxative compositions and methods of use thereof
US11007170B2 (en) 2017-02-02 2021-05-18 Panaxia Pharmaceutical Industries Ltd. Composition for buccal or sublingual administration of cannabis extract and methods for making same
US10143656B1 (en) 2017-08-04 2018-12-04 Braintree Laboratories, Inc. Solid oral sulfate salt formulations for cleaning a colon and methods of using same
JP2023549291A (ja) * 2020-10-26 2023-11-22 ブレーンツリー・ラボラトリーズ・インコーポレイテッド 結腸洗浄のための硫酸塩製剤
CN116509809B (zh) * 2023-04-19 2024-12-03 山东齐都药业有限公司 复方硫酸钠片剂及其制备方法与应用
WO2024256873A1 (en) 2023-06-15 2024-12-19 Sebela Ireland Limited Methods of administering safe colon cleansing compositions

Family Cites Families (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3873694A (en) 1973-09-27 1975-03-25 Cpc International Inc Direct compression tabletting composition and pharmaceutical tablets produced therefrom
JPS5438167B2 (cg-RX-API-DMAC7.html) 1974-04-27 1979-11-19
JPS5562012A (en) 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
GB2058565B (en) 1979-09-21 1983-12-07 Leo Pharm Prod Ltd Layer tablets
NZ198241A (en) 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
DE3134591A1 (de) 1981-09-01 1983-03-10 Bayer Ag, 5090 Leverkusen Neue arzneimittelpraeparationen fuer glykosidhydrolasen-inhibitoren
JPS5839618A (ja) 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
DE3266580D1 (en) 1981-12-02 1985-10-31 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
JPS59101423A (ja) 1982-12-02 1984-06-12 Takada Seiyaku Kk 新規なニフエジピン固形製剤
JPS6097919A (ja) 1983-11-01 1985-05-31 Furointo Sangyo Kk 圧縮成形用賦形剤の製造方法
NL8400911A (nl) 1984-03-22 1985-10-16 Dagra Nv Werkwijze ter bereiding van een farmaceutische toedieningsvorm die tetracycline of doxycyclinezouten bevat.
AU6196786A (en) 1985-08-01 1987-03-05 Braintree Laboratories Inc. Low-sodium laxative and lavage formulation
US4753801A (en) 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets
EP0281200B1 (en) 1987-03-02 1994-01-19 Yamanouchi Europe B.V. Pharmaceutical composition, pharmaceutical granulate and process for their preparation
IL86859A (en) 1987-07-10 1991-12-15 E Z Em Inc Aqueous cathartic solution containing inorganic salts
NO168563C (no) 1987-09-28 1992-03-11 Collett Marwell Hauge As Anvendelse av en organoleptisk akseptabel blanding av magnesiumsalter som mineraladditiv
US4837030A (en) 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds
JPH0194937A (ja) * 1987-10-06 1989-04-13 Yokohama Yushi Kogyo Kk 微粉状ミネラル類の被覆物の製造方法
US5211958A (en) 1987-11-30 1993-05-18 Gist-Brocades, N.V. Pharmaceutical composition and process for its preparation
US5274001A (en) 1987-12-24 1993-12-28 Borody Thomas J Orthostatic lavage solutions
AU3367589A (en) 1988-04-05 1989-11-03 Dale Driver Dietary mineral sulfur supplement
JPH0816061B2 (ja) 1988-07-13 1996-02-21 森下ルセル株式会社 腸管洗浄液用組成物と腸管洗浄液
IT1229568B (it) 1989-04-17 1991-09-04 Giuliani Spa Composizione farmaceutica per uso orale adatta all'impiego nel lavaggio gastro intestinale, in particolare per uso diagnostico, oppure come lassativo catartico.
US5654003A (en) * 1992-03-05 1997-08-05 Fuisz Technologies Ltd. Process and apparatus for making tablets and tablets made therefrom
RU94042719A (ru) 1992-03-11 1997-02-20 Дзе Проктер Энд Гэмбл Компани (US) Содержащий psyllium состав питьевых смесей
JPH08505609A (ja) 1992-11-24 1996-06-18 ブロック・ドラッグ・カンパニー・インク 胃腸洗浄用薬剤組成物
US5958458A (en) 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
US5498425A (en) 1995-03-17 1996-03-12 Block Drug Company, Inc. Phosphosoda buffered saline laxative
US5710183A (en) 1995-07-14 1998-01-20 Halow; George M. Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent
AUPN634595A0 (en) 1995-11-03 1995-11-30 Borody, Thomas Julius Improved method for colonic evacuation
DE69627170T2 (de) 1996-05-08 2004-03-04 Aronchick, Graig A. Nichtwässrige abführmittel für den kolon
US6162464A (en) 1997-03-31 2000-12-19 Inkine Pharmaceutical, Inc. Non-aqueous colonic purgative formulations
EP0975327B1 (en) 1997-04-18 2003-07-02 Janssen Pharmaceutica N.V. Use of 5ht3 antagonists for promoting intestinal lavage
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US6350470B1 (en) 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
US6200604B1 (en) 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
CA2348024C (en) 1998-10-30 2008-02-19 Mcneil-Ppc, Inc. Granular, free-flowing pharmaceutical composition, and straw-like dosage form for oral administration thereof
US6645481B1 (en) 2000-09-28 2003-11-11 Braintree Laboratories, Inc. Method of achieving overnight laxation and control of bowel function
US6887492B2 (en) 2000-12-14 2005-05-03 Leiner Health Services Corp. Magnesium plus interactive agent delivery
AUPR590701A0 (en) 2001-06-25 2001-07-19 Colocaps Pty Ltd Laxative preparation
AUPS088702A0 (en) 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
US6946149B2 (en) 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
US20040071779A1 (en) 2002-10-09 2004-04-15 Keiser Dale Arthur Gelled laxative compositions
US7291324B2 (en) 2002-10-22 2007-11-06 Braintree Laboratories Inc. Method of bowel cleansing
GB0224909D0 (en) 2002-10-25 2002-12-04 Norgine Europe Bv Colon cleansing compositions
PT1663257E (pt) 2003-07-09 2009-03-27 Braintree Lab Utilização de laxantes para tratamento da síndrome do cólon irritável
US7687075B2 (en) 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent
GB0409104D0 (en) 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
EP2281562A3 (en) 2004-06-04 2011-11-23 Braintree Laboratories, Inc. Method of bowel cleansing
WO2007013093A2 (en) 2005-04-01 2007-02-01 Shiv Prakash Laxative formulation containing a triphala extract
WO2006118562A1 (en) 2005-04-29 2006-11-09 Inkine Pharmaceutical Company, Inc. Purgative composition and uses thereof
JP5276435B2 (ja) 2005-05-06 2013-08-28 セイリックス ファーマシューティカルズ, インコーポレイティッド ポリエチレングリコールの結腸の下剤組成物
US20070087056A1 (en) 2005-08-09 2007-04-19 Claudia Guthmann Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility
US20070082061A1 (en) 2005-10-07 2007-04-12 Nelson Ayala Reduction of saltiness with sweeteners
EP1976520B1 (en) 2005-12-29 2011-04-27 Braintree Laboratories, Inc. Kit comprising an osmotic laxative and a stimulant laxative for preparing the colon for virtual colonoscopy
US8067033B2 (en) * 2007-11-30 2011-11-29 Horizon Pharma Usa, Inc. Stable compositions of famotidine and ibuprofen
US7998510B2 (en) 2006-08-17 2011-08-16 C. B. Fleet Company, Inc. Low dose colonic cleansing system
AU2008253583A1 (en) 2007-05-17 2008-11-27 David Lubowski Combination laxative compositions comprising a colonic stimulant and a bulking laxative
CN101938994A (zh) 2007-10-17 2011-01-05 托马斯杰弗逊大学 肠道催泻剂及其用途
AU2009205927A1 (en) 2008-01-16 2009-07-23 Braintree Laboratories, Inc. Sulfate salt prophylaxis and therapies
US20090258090A1 (en) 2008-04-11 2009-10-15 Braintree Laboratories, Inc. Colon cleansing solution
PT2294012E (pt) 2008-05-07 2014-10-15 Salix Pharmaceuticals Ltd Administração de um agente de limpeza intestinal e de um antibiótico para o tratamento de doença intestinal
US20100255122A1 (en) 2009-04-02 2010-10-07 Garren Mary L Edible gelatin bowel preparation and bowel cleansing method
JP5759450B2 (ja) 2009-04-21 2015-08-05 バックウィッチ, デール, アール.BACHWICH, Dale, R. 大腸洗浄システム
US20100285164A1 (en) * 2009-05-11 2010-11-11 Jrs Pharma Orally Disintegrating Excipient
GB0912487D0 (en) 2009-07-17 2009-08-26 Norgine Bv Improvements in and relating to colon cleansing compositions
GB0913295D0 (en) 2009-07-30 2009-09-02 Norgine Bv Improvements in and relating to pharmaceutical compositions
AU2011226324B2 (en) 2010-03-10 2015-09-24 Nogra Pharma Limited Compositions for colon lavage and methods of making and using same
EP2544543A1 (en) 2010-03-12 2013-01-16 Scott Cordray Method of treatment
JP5665372B2 (ja) * 2010-06-02 2015-02-04 旭化成ケミカルズ株式会社 速崩壊性固形製剤
US20130189377A1 (en) 2010-07-27 2013-07-25 Norgine Bv Compositions
NZ611148A (en) 2010-11-04 2015-09-25 Norgine Bv Formulations comprising polyethylene glycol
CN103338768B (zh) 2010-12-13 2019-04-19 萨利克斯药品有限公司 胃和结肠的配制剂及其制备和使用方法
JP5876418B2 (ja) * 2010-12-28 2016-03-02 大鵬薬品工業株式会社 口腔内崩壊錠剤
WO2012102799A2 (en) 2011-01-28 2012-08-02 Shaver William A Method, composition and package for bowel cleansing
PT2862566T (pt) 2011-01-31 2022-06-02 Norgine Healthcare B V Melhorias em, e relativas a, composições
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
HUE037452T2 (hu) 2011-04-15 2018-08-28 Braintree Laboratories Inc Tranzitidõ javító szulfát sók
US8778907B2 (en) 2011-04-27 2014-07-15 Cumberland Pharmaceuticals Lactulose for bowel evacuation
US20140235730A1 (en) 2011-09-23 2014-08-21 Gavis Pharmaceuticals, Llc Solid, edible, chewable laxative composition
JP6240610B2 (ja) 2011-10-27 2017-11-29 サリックス ファーマシューティカルズ,インコーポレイテッド 電解質下剤
US9149493B2 (en) 2011-11-28 2015-10-06 Alfa Wassermann Spa Compositions for bowel cleansing and use thereof
KR20150046310A (ko) 2012-08-29 2015-04-29 샐릭스 파마슈티컬스 인코포레이티드 완화제 조성물 및 변비 및 관련 위장관 질병 및 증상 치료를 위한 방법
CN105007915B (zh) 2012-09-11 2018-09-28 诺金股份有限公司 包含peg和抗坏血酸的组合物
US20140087007A1 (en) 2012-09-27 2014-03-27 Braintree Laboratories, Inc. Bowel cleansing preparations
HK1214519A1 (zh) 2013-03-15 2016-07-29 Braintree Laboratories, Inc. 雙用途硫酸鹽口服藥物組合物片劑及其使用方法

Similar Documents

Publication Publication Date Title
JP2016514677A5 (cg-RX-API-DMAC7.html)
JP7028829B2 (ja) 口腔内崩壊錠及びその製造方法
CN106456550A (zh) 避免乙醇剂量倾泻的多颗粒
JP2016540021A5 (cg-RX-API-DMAC7.html)
JP2011098964A5 (cg-RX-API-DMAC7.html)
JP2017525712A5 (cg-RX-API-DMAC7.html)
JP2016516698A5 (cg-RX-API-DMAC7.html)
JP2014501267A (ja) メサラジン制御放出用の経口用医薬錠剤および前記錠剤を得るための製法
JP2016508516A5 (cg-RX-API-DMAC7.html)
JP7674080B2 (ja) アビラテロン酢酸エステル含有製剤
JP2010143836A (ja) 口腔内崩壊錠用組成物
JP2020509052A5 (cg-RX-API-DMAC7.html)
CN109646412A (zh) 一种肠溶药用组合物及其制备方法和应用
JP6580414B2 (ja) 生薬末含有錠剤
JP5347092B2 (ja) アンドログラフィス抽出物製剤
WO2016147108A1 (en) Pharmaceutical compositions of dimethyl fumarate
WO2016012898A1 (en) Oral pharmaceutical composition of lurasidone
JP7407364B2 (ja) ラメルテオン含有固形製剤
JP6485120B2 (ja) 固形製剤
JP7133811B2 (ja) 錠剤
JP5710301B2 (ja) 口腔内崩壊型錠及びその製造方法
KR20070119654A (ko) 의약용 조성물
IL273627B1 (en) Abuse deterrent morphine sulfate dosage forms
JP6824816B2 (ja) 口腔内崩壊性被覆錠剤及び口腔内崩壊性被覆錠剤の被覆層用組成物
JP6927763B2 (ja) 清肺湯エキス末を含有する錠剤